A recent Cell Metabolism study explores the therapeutic potential of circadian-modulating interventions to treat Alzheimer's disease (AD). Study: Circadian modulation by time-restricted feeding ...
A recent study published in the journal Nature reported the co-aggregation of medin, a fragment of lactadherin, with vascular amyloid-β in Alzheimer’s disease (AD). Amyloidosis is caused by systemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results